Abivax ADR

ABVXNASDAQ · USD
91.06USD0.00 (-4.02%)
239

Abivax ADR (ABVX) Option Chain

As of September 24, 2026, Abivax ADR is trading at $91.06, a -4.02% change from the previous close. The nearest expiration is Oct 2, 2026. Implied volatility is 66.3%. IV Rank is 19%.

Read more

Tracking the ABVX option chain helps you see every strike and expiry on Abivax ADR in one view, so you can quickly identify the contracts that fit your thesis and your risk. Abivax ADR's option chain lays out bids, asks, volume, open interest, and Greeks across calls and puts, giving you the full map of ABVX options activity at a glance. Use our scanner to monitor the ABVX option chain in real time and filter for the ABVX options trades that actually meet your criteria.

An option chain is the complete listing of all available option contracts on an underlying, organized by expiration date and strike price. For ABVX stock options, the chain shows side-by-side call and put data, making it easy to compare premiums, assess liquidity, and spot pricing dislocations. Reading the ABVX option chain effectively means looking beyond the last price — implied volatility by strike, volume-to-open-interest ratios, and bid-ask spreads all tell you where ABVX stock options are being actively traded and where they are not.

ABIVAX Société Anonyme discovers and optimizes drugs for the treatment of inflammatory diseases, infectious diseases, and cancer in France. Its principal products include ABX464 that is in Phase IIb clinical trials for the treatment of ulcerative colitis and Crohn's Disease, as well as for COVID-19; Phase IIa clinical trial for the treatment of rheumatoid arthritis diseases; and has completed Phase IIa clinical trial for the treatment of viral remission in patients with HIV. It also develops ABX 196, an immune enhancer candidate that is in Phase 1/2 clinical trials for the treatment of hepatocellular cancer.

In addition, the company engages in the research programs for the treatment of Dengue fever, influenza, and respiratory syncytial virus. ABIVAX Société Anonyme has license contracts with the French National Centre for Scientific Research, the University of Montpellier, and the Institut Curie. The company was incorporated in 2013 and is headquartered in Paris, France.

Credit spreads, long calls, iron condors, calendar trades — every strategy starts with the same raw material: a clean, complete option chain. Our scanner pulls Abivax ADR's full chain across every expiry, highlights the most liquid strikes, and lets you screen ABVX options by the metrics that matter, from IV skew to volume surges. Stop scrolling through endless rows of ABVX stock options — let the full option chain come to you, pre-filtered and ready to trade.

Stock Statistics

  • IndustryBiotechnology
  • SectorHealthcare
  • IV percentile37.30% Neutral
  • Market cap (M$)7,954
  • 52 weeks high-38.82%
  • 52 weeks low30.44%
  • Analyst recommendationStrong Buy
    1.26
  • Target price$161.18
    77.00% above the current stock price
  • Dividend—
  • Payout ratio—
  • Earnings date2026-12-21
  • P/E—
  • Future P/E—
  • EPS (ttm)-6.10
  • EPS growth next 5 years42.77%

As of September 24, 2026

2026-10-02
5 strikes
Default
CALLsPUTs
Prob. OTM %Open InterestVolumeExtrinsic ValueIntrinsic ValueBidAskStrikeMoneyness %BidAskIntrinsic ValueExtrinsic ValueVolumeOpen InterestProb. OTM %
Loading option chain…

As of September 24, 2026

Scan the full option chain in one place

Browse the full ABVX option chain across every strike and expiration, filter by IV, volume, and open interest, and evaluate your trade without switching tools.

Start your 14-day free trial